IRadimed CorporationIRMDNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank59
3Y CAGR+9.0%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+9.0%/yr
vs -19.8%/yr prior
Acceleration
+28.8pp
Accelerating
Percentile
P59
Within normal range
vs 3Y Ago
1.3x
Solid growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 3.81% |
| Q3 2025 | 0.67% |
| Q2 2025 | 24.98% |
| Q1 2025 | -6.36% |
| Q4 2024 | 0.19% |
| Q3 2024 | 2.88% |
| Q2 2024 | 18.51% |
| Q1 2024 | -7.97% |
| Q4 2023 | -12.62% |
| Q3 2023 | 18.99% |
| Q2 2023 | 23.85% |
| Q1 2023 | -5.80% |
| Q4 2022 | 2.94% |
| Q3 2022 | -0.82% |
| Q2 2022 | 35.50% |
| Q1 2022 | -1.11% |
| Q4 2021 | 0.73% |
| Q3 2021 | 67.38% |
| Q2 2021 | 3.78% |
| Q1 2021 | 172.95% |
| Q4 2020 | -17.04% |
| Q3 2020 | 126.79% |
| Q2 2020 | -497.31% |
| Q1 2020 | -67.07% |
| Q4 2019 | -11.11% |
| Q3 2019 | 6.02% |
| Q2 2019 | 56.94% |
| Q1 2019 | -15.56% |
| Q4 2018 | 23.81% |
| Q3 2018 | -13.57% |
| Q2 2018 | 54.09% |
| Q1 2018 | 8.76% |
| Q4 2017 | 409.92% |
| Q3 2017 | -40.15% |
| Q2 2017 | 237.42% |
| Q1 2017 | -115.84% |
| Q4 2016 | -41.96% |
| Q3 2016 | -22.35% |
| Q2 2016 | -4.06% |
| Q1 2016 | 3.85% |